Accent Therapeutics

Biotech · Private

Small molecule therapeutics targeting RNA-modifying proteins

Claim this profile

Follows are private to you and power your alerts

Updated · accenttx.com

Sector
Biotech
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
35 pending · first 2024
Rank in peer group#339 of 1449

Capital timeline

No federal awards or Form D filings are on record for this company.

Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.

Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards

Founder? Add funding context

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#339 · top 23%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 38
  • PendingInhibitors Of KIF18A And Uses ThereofUSPTOApplication 19103998
  • PendingInhibitors Of KIF18A And Uses ThereofUSPTOApplication 19103126
  • GrantedInhibitors Of KIF18A And Uses ThereofUSPTOUS 12,391,709
Show all 38 patent records
  • Inhibitors Of KIF18A And Uses ThereofMar 5, 2026 · Application 19103998Pending
  • Inhibitors Of KIF18A And Uses ThereofMar 5, 2026 · Application 19103126Pending
  • Inhibitors Of KIF18A And Uses ThereofAug 19, 2025 · US 12,391,709Granted
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofJun 5, 2025 · Application 18839362Pending
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofMay 8, 2025 · Application 18924385Pending
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofFeb 25, 2025 · US 12,233,065Granted
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofDec 10, 2024 · US 12,162,867Granted
  • METTL3 ModulatorsFeb 15, 2024 · Application 18031920Pending
  • METTL3 ModulatorsJan 26, 2023 · Application 17770708Pending
  • METTL3 ModulatorsNov 24, 2022 · Application 17770714Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication PCTUS2023030109Pending
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofApplication 63532210Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication 63463622Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication 63463617Pending
  • Assays For Monitoring Inhibition Of Rna Helicase DHX9Application 63459632Pending
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofApplication PCTUS2023013303Pending
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofApplication PCTUS2023012929Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication 19140406Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication 63434554Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication 63399003Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication 63397458Pending
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofApplication 63311649Pending
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofApplication 63309917Pending
  • METTL3 ModulatorsApplication PCTUS2021054822Pending
  • METTL3 ModulatorsApplication PCTUS2020056873Pending
  • METTL3 ModulatorsApplication 63091529Pending
  • METTL3 ModulatorsApplication 62926072Pending
  • Assays For Monitoring Inhibition Of Rna Helicase DHX9Application 19475686Pending
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofApplication 19510546Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication PCTUS2025032277Pending
  • Methods Of Treating Cancer With Inhibitors Of The Rna Helicase DHX9Application PCTUS2024050858Pending
  • Inhibitors Of Rna Helicase DHX9 And Uses ThereofApplication PCTUS2024041740Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication 63656255Pending
  • Assays For Monitoring Inhibition Of Rna Helicase DHX9Application PCTUS2024024695Pending
  • Methods Of Treating Cancer With Inhibitors Of The Rna Helicase DHX9Application 63618886Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication PCTUS2023085427Pending
  • Methods Of Treating Cancer With Inhibitors Of The Rna Helicase DHX9Application 63543489Pending
  • Inhibitors Of KIF18A And Uses ThereofApplication PCTUS2023030544Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .